Lipids, Blood Pressure, Kidney - What Was New in 2011?

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2012 Feb 14

PMID 22328891

Citations 36

Authors

Marcin Barylski

Jolanta Malyszko

Jacek Rysz

Michal Mysliwiec

Maciej Banach

Affiliations

Soon will be listed here.

Abstract

The year 2011 was very interesting regarding new studies, trials and guidelines in the field of lipidology, hypertensiology and nephrology. Suffice it to mention the new European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias, American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) guidelines on hypertension in the elderly, and many important trials presented among others during the American Society of Nephrology (ASN) Annual Congress in Philadelphia and the AHA Annual Congress in Orlando. The paper is an attempt to summarize the most important events and reports in the mentioned areas in the passing year.

Citing Articles

[Mapping access to hypertension management services by general practitioners in Burkina Faso in 2020].

Yameogo R, Mandi D, Bamouni J, Zabsonre P, Meda N Pan Afr Med J. 2024; 48:173.

PMID: 39650827 PMC: 11624475. DOI: 10.11604/pamj.2024.48.173.34706.

Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertension.

Poreba R, Gac P, Poreba M, Derkacz A, Chachaj A, Mazur G Arch Med Sci. 2015; 11(3):521-9.

PMID: 26170844 PMC: 4495148. DOI: 10.5114/aoms.2015.52354.

Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II.

Vitlianova K, Georgieva J, Milanova M, Tzonev S Arch Med Sci. 2015; 11(1):85-91.

PMID: 25861293 PMC: 4379372. DOI: 10.5114/aoms.2015.49208.

Lipid-lowering therapy in older persons.

Aronow W Arch Med Sci. 2015; 11(1):43-56.

PMID: 25861289 PMC: 4379366. DOI: 10.5114/aoms.2015.48148.

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Banach M, Rizzo M, Toth P, Farnier M, Davidson M, Al-Rasadi K Arch Med Sci. 2015; 11(1):1-23.

PMID: 25861286 PMC: 4379380. DOI: 10.5114/aoms.2015.49807.

References

Navarro-Gonzalez J, Mora C, Muros M, Jarque A, Herrera H, Garcia J . Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension. J Hypertens. 2008; 26(11):2168-75. DOI: 10.1097/HJH.0b013e32830e2545. View

Foley R, Gilbertson D, Murray T, Collins A . Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med. 2011; 365(12):1099-107. DOI: 10.1056/NEJMoa1103313. View

Katsiki N, Mikhailidis D, Athyros V, Hatzitolios A, Karagiannis A, Banach M . Are we getting to lipid targets in real life?. Arch Med Sci. 2012; 6(5):639-41. PMC: 3298327. DOI: 10.5114/aoms.2010.17073. View

Vulic D, Loncar S, Krneta M, Skrbic R, Lazarevic A, Lee B . Risk factor control and adherence to treatment in patients with coronary heart disease in the Republic of Srpska, Bosnia and Herzegovina in 2005-2006. Arch Med Sci. 2012; 6(2):183-7. PMC: 3281337. DOI: 10.5114/aoms.2010.13891. View

Olsen M, Wachtell K, Ibsen H, Lindholm L, Kjeldsen S, Omvik P . Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy. J Hypertens. 2011; 29(5):997-1004. DOI: 10.1097/HJH.0b013e328344daa3. View

Barylski M, Mikhailidis D, Ciebiada M, Rysz J, Banach M . Gender differences in the treatment of ischemic heart disease. Curr Pharm Des. 2011; 17(11):1059-69. DOI: 10.2174/138161211795656936. View

Bisognano J, Bakris G, Nadim M, Sanchez L, Kroon A, Schafer J . Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011; 58(7):765-73. DOI: 10.1016/j.jacc.2011.06.008. View

Bielecka-Dabrowa A, Rysz J, Mikhailidis D, Banach M . What is the risk of hyperkalaemia in heart failure?. Expert Opin Pharmacother. 2011; 12(15):2329-38. DOI: 10.1517/14656566.2011.601743. View

Irzmanski R, Banach M, Piechota M, Kowalski J, Barylski M, Cierniewski C . Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters. Clin Exp Hypertens. 2007; 29(3):149-64. DOI: 10.1080/10641960701361593. View

10.

Aronow W, Ahmed M, Ekundayo O, Allman R, Ahmed A . A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults. Am J Cardiol. 2008; 103(1):130-5. PMC: 2909744. DOI: 10.1016/j.amjcard.2008.08.037. View

11.

Banach M, Aronow W . Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn. 2011; 121(7-8):253-8. View

12.

Krause T, Lovibond K, Caulfield M, McCormack T, Williams B . Management of hypertension: summary of NICE guidance. BMJ. 2011; 343:d4891. DOI: 10.1136/bmj.d4891. View

13.

Nicholls S, Ballantyne C, Barter P, Chapman M, Erbel R, Libby P . Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011; 365(22):2078-87. DOI: 10.1056/NEJMoa1110874. View

14.

Levy D, Larson M, Vasan R, Kannel W, Ho K . The progression from hypertension to congestive heart failure. JAMA. 1996; 275(20):1557-62. View

15.

He F, MacGregor G . Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011; 378(9789):380-2. DOI: 10.1016/S0140-6736(11)61174-4. View

16.

Vincenti F, Dritselis A, Kirkpatrick P . Belatacept. Nat Rev Drug Discov. 2011; 10(9):655-6. DOI: 10.1038/nrd3536. View

17.

Gradman A, Basile J, Carter B, Bakris G . Combination therapy in hypertension. J Clin Hypertens (Greenwich). 2011; 13(3):146-54. PMC: 8673364. DOI: 10.1111/j.1751-7176.2010.00397.x. View

18.

Gordon L, Ragoobirsingh D, Morrison E, McGrowder D, Choo-Kang E, Martorell E . Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch Med Sci. 2012; 6(5):701-8. PMC: 3298338. DOI: 10.5114/aoms.2010.17084. View

19.

Ketteler M, Martin K, Cozzolino M, Goldsmith D, Sharma A, Khan S . Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study. Nephrol Dial Transplant. 2011; 27(5):1942-9. PMC: 3339443. DOI: 10.1093/ndt/gfr531. View

20.

Preiss D, Seshasai S, Welsh P, Murphy S, Ho J, Waters D . Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011; 305(24):2556-64. DOI: 10.1001/jama.2011.860. View